Medication machine trial aims to improve access for rural patients

Groundbreaking technology, funded by Health and Care Research Wales, is being trialled in Dolgellau to allow patients to pick up urgent medication at times when local pharmacies are closed. 

The REMEDY machine is a joint project between Betsi Cadwaladr University Health Board and Bangor University, in collaboration with the manufacturer and supplier and Oxford University. 

Making medicines more accessible to patients is essential to reducing pressures on out-of-hours and emergency services.  

During the two-year trial, people who contact NHS 111 out of hours and require medication urgently will be offered the option to collect it directly from the machine outside Dolgellau Hospital via a unique code. 

Dr Adam Mackridge, Strategic Lead for Community Pharmacy at Betsi Cadwaladr University Health Board, said:

It is very simple and will be a huge benefit to the population in the Dolgellau area who are a considerable distance from other services, particularly on weekends and evenings. 

“This is a really positive collaboration to try to help improve equity of medicines access and reduce health inequalities.”  

Dr Rebecca Payne, Out-of-Hours GP and Clinical Academic, said: “This machine has been developed specifically for the project with the manufacturer, Videosystems, and supplier, Omnicell, in partnership with the University and the Health Board. Although it’s been adapted from an existing technology, using it this way is a European first.  

“It’s fantastic to see North Wales leading the way, developing cutting edge technology which can make a real difference to patients, particularly those in rural areas like Dolgellau.” 

Michael Bowdery, Head of Programmes and Joint Interim Director at Health and Care Research Wales, said: “We are once again pleased to be able to provide funding for a range of personal and project awards that will support the development of our researchers while addressing important areas of health and care need.” 

Sign up to our weekly newsletter and keep up with the latest research news, funding opportunities and other useful information.